The US relies heavily on India to stock its medicine cabinets, and any slowdown in output could leave pharmacies short of drugs used regularly by millions of Americans.
Last week, India's Ambassador to the US Taranjit Singh Sandhu held virtual meetings with top US pharma companies, including Pfizer, and said India is seeking to encourage investments.
On 26 April, China suspended for 15 days cargo flights by Sichuan Airlines that transports medical supplies to India. India imports 70% of its pharmaceutical raw materials from China.
Exports are expected to rise by over 16% this fiscal. The industry recorded less than 3% growth in 2014-15 and 2017-18. In 2016-17, there was negative growth of 0.59%.
Report highlights loopholes in distribution chain of pharma products, but also stresses on India’s important role in ‘promoting local and global health goals’.
NPPA has issued a list of ‘overcharging cases’ under litigation, which includes matters dating back to 1997 & those where firms have moved court against the allegations.
The expert panel, consisting of 5 members from the industry and a govt official, has highlighted archaic labour laws & flawed definitions of fast-tracking mechanisms as hiccups.
In a letter to pharma organisations, govt mentioned a complaint against an event to be held by ‘Indian Psychotropic Society’. Industry members say they have never heard the name.
India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.
Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.
COMMENTS